Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Sichuan Biokin Pharmaceutical (688506 CH)
Watchlist
22
Analysis
Health Care
•
China
Sichuan Biokin Pharmaceutical Co.,Ltd. operates as a pharmaceutical company. The Company produces children's medicine, cardiovascular drugs, anesthetics, chronic disease drugs, and more. Sichuan Biokin Pharmaceutical conducts businesses worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Shanghai Rural Commercial Bank
•
20 Jun 2024 17:42
Quiddity Leaderboard CSI 300/500 Dec 24: A Long-Short Basket Trade Idea with High Momentum
The CSI 300 and CSI 500 index rebal events could see one-way flows of US$2bn and US$2.5bn respectively. Since roughly a third of the reference...
Janaghan Jeyakumar, CFA
Follow
348 Views
Share
bullish
•
United Nova Technology
•
03 Jun 2024 05:28
STAR50/STAR100 Index Rebalance: Index Committee Flip-Flops on Profitability
There are 3 changes for the STAR50 index and 9 for the STAR100. Some stocks will have same way flows from other index trackers. United Nova Tech is...
Brian Freitas
Follow
393 Views
Share
bullish
•
Cross Asset Strategy
•
27 Feb 2024 11:51
•
Syndicated
CX Daily: Chinese Pharma Turns to Global Deals to Cure Capital Crunch
Biotech / Cover story: Chinese pharma turns to global deals to cure capital crunch After enduring the chill of a prolonged capital winter, China’s...
Caixin Global
Follow
195 Views
Share
bullish
•
Baimtec Material
•
25 Feb 2024 10:00
STAR50 Index Rebalance: Three Changes a Side; One Surprise Change
There are 3 changes for the STAR50 in March. Estimated one-way turnover is 2.9% resulting in a 1-way trade of CNY 4.08bn with over 2.5x ADV to...
Brian Freitas
Follow
558 Views
Share
bearish
•
Shanghai Medicilon
•
13 Feb 2024 08:46
China Healthcare Weekly (Feb.12) - New Pricing Mechanism for Drugs, China Biotech M&A, Medicilon
NHSA released regulations to establish new mechanism for pricing newly listed chemical drugs. It would be difficult for Chinese biotech to be...
Xinyao (Criss) Wang
Follow
377 Views
Share
Previous
1
2
3
4
5
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x